METASTATIC EWING SARCOMA
Clinical trials for METASTATIC EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC EWING SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug shows promise for rare bone cancers
Disease control OngoingThis study tests a drug called cabozantinib in people whose osteosarcoma or Ewing sarcoma has returned or worsened after standard treatment. The drug works by blocking enzymes that help cancer cells grow and by cutting off the blood supply tumors need. The main goal is to see if …
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:04 UTC
-
Could a targeted drug boost chemo for aggressive bone cancer?
Disease control OngoingThis study tests whether adding a drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves how long the cancer stays away. This is a phase 3 stud…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Hope for kids with advanced bone cancer: new combo trial launches
Disease control OngoingThis study tests whether adding three drugs (vincristine, irinotecan, and regorafenib) to standard chemotherapy helps people with metastatic Ewing sarcoma live longer without the cancer growing. About 437 participants aged 1 to 50 with newly diagnosed, spread cancer will be rando…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 06, 2026 16:14 UTC